U.S. Markets open in 9 hrs 21 mins

AbbVie Is 'The New Cash King' As It Takes On Botox-Maker Allergan

ALLISON GATLIN
AbbVie Is 'The New Cash King' As It Takes On Botox-Maker Allergan

Analysts offered mixed views Wednesday on AbbVie's $63 billion takeover of Botox-maker Allergan — a deal meant to lessen the pharmaceutical company's dependence on arthritis drug Humira.